Researchers have found a groundbreaking way to tackle influenza thanks to an accidental laboratory discovery. This finding reveals that different strains of flu employ distinct strategies to invade human cells. According to SWNS, scientists learned that by targeting specific molecules these viruses depend on, they can be stopped from entering new cells, effectively preventing their replication.
Investigation and Insights
In their attempt to understand influenza replication, researchers uncovered that H1N1 and H3N2 influenza A viruses, the most common strains, use different proteins to penetrate human cells. This knowledge paves the way for improved preventive medications, as current flu tests and treatments cannot distinguish between these strains.
The study, published in The Journal of Virology, originally aimed to map how viral RNA segments transport within cells to create new viral particles. The team worked with H1N1 and H3N2 viruses isolated from patients’ nasal passages, identifying a cellular pathway that unexpectedly blocked virus entry into lung cells. The absence of the human protein Rab11B prevented H3N2 viruses from infecting lung cells, while H1N1 was unaffected.
Challenge to Previous Assumptions
This discovery challenges the scientific belief that all flu viruses enter cells similarly, showing that H1N1 and H3N2 require different proteins for cell entry. This insight may lead to treatments that specifically target the right protein to block virus entry.
Although these findings highlight crucial cellular pathways for viral entry, they were derived from isolated cells. Further investigations are necessary to confirm the safety and effectiveness of blocking Rab11B in a live human respiratory system.
Dr. Emily Bruce, the study’s principal investigator from the University of Vermont’s Larner College of Medicine, expressed hope that curiosity-based research like this will contribute to novel strategies in treating and preventing influenza infections.
Further Research Needed
The team is planning more research to establish whether the reliance on Rab11B is a fundamental trait of the H3N2 virus or unique to current flu strains. These efforts may reshape strategies for flu prevention and treatment.